• INTRODUCTION
    • Chondral defects of the knee are common and their management is challenging.
  • SOURCE OF DATA
    • Current scientific literature published in PubMed, Google scholar, Embase and Scopus.
  • AREAS OF AGREEMENT
    • Membrane-induced autologous chondrocyte implantation (mACI) has been used to manage chondral defects of the knee.
  • AREAS OF CONTROVERSY
    • Hyaluronic acid membrane provides better outcomes than a collagenic membrane for mACI in the knee at midterm follow-up is controversial.
  • GROWING POINTS
    • To investigate whether hyaluronic acid membrane may provide comparable clinical outcomes than collagenic membranes for mACI in focal defects of the knee.
  • AREAS TIMELY FOR DEVELOPING RESEARCH
    • Hyaluronic acid membrane yields a lower rate of failures and revision surgeries for mACI in the management of focal articular cartilage defects of the knee compared with collagenic scaffolds at midterm follow-up. No difference was found in patient reported outcome measures (PROMs). Further comparative studies are required to validate these results in a clinical setting.